Cooley (UK) LLP

Emerging CompaniesMergers & AcquisitionsPublic CompaniesLife Sciences Corporate Partnering & LicensingIntellectual PropertyHealth CareLife SciencesMedtech

Nicola Maguire is a partner in Cooley's Life Sciences practice and is resident in the London office. She has developed a practice specialising in advising life sciences companies and other clients whose businesses have a significant reliance on intellectual property.

Many of the transactions on which Nicola works have a significant international element, with parties in the U.S. or Europe. Nicola's experience includes advising on the acquisition for Swedish listed company Meda AB of an Italian specialty pharma company, Rottapharm, for the Danish, listed company Ambu A/S on its acquisition of King Systems, a US subsidiary of UK listed company, Consort Medical, on the creation of an Indian joint venture between the Wellcome Trust and Merck and on the creation of a joint venture between Swedish company, Karolinska Development and UK based Rosetta Capital. Transactions such as this illustrate the cross-border nature of Nicola's practice. She has particular expertise advising clients at all stages of development, from early stage startups to listed companies, and on mergers and acquisitions, joint ventures and equity fundings. 

Nicola's practice also includes advising on general commercial matters such as materials transfer agreements, intellectual property licences, research and collaboration agreements and distribution and manufacturing agreements. Recent transactions include acting for the Wellcome Trust on its collaboration relating to dengue fever with the University of Leuven and Janssen and for King's College London on a licence and development agreement with UCB. 

Nicola was previously a partner at Reed Smith from 2005 – 2015 and Bird & Bird from 2001 to 2005. Previously, she worked at GE Lighting and Cable & Wireless Communications.

French

University of BristolPGD, 2004 College of Law, GuildfordLPC, 1987 Manchester UniversityLLB, 1986